ReCode Therapeutics

company

Number of Lead Investors

Number of Investors

ReCode Therapeutics is funded by 15 investors. Leaps by Bayer and Matrix Capital Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Leaps by Bayer	Yes	Series B
Matrix Capital Management	Yes	Series B
EcoR1 Capital	Yes	Series B
Amgen Ventures	-	Series B
Pfizer Venture Investments	-	Series B
Sanofi Ventures	-	Series B
Colt Ventures	-	Series B
Hunt Technology Ventures	-	Series B
MPM Capital	-	Series B
NS Investment	-	Series B
OrbiMed	-	Series B
OUP (Osage University Partners)	-	Series B
Superstring Capital	-	Series B
Tekla Capital Management	-	Series B
Vida Ventures	-	Series B